At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> SEC Filings

SEC Filings

  
Filing Description Date Filed Sorted Descending Size View  
4 dentzer, james e Jul 2, 2008 19.7 KB View HTML View PDF View XLS  
4 patterson, matthew r Jun 24, 2008 25.9 KB View HTML View PDF View XLS  
4 patterson, matthew r Jun 20, 2008 27.5 KB View HTML View PDF View XLS  
4 patterson, matthew r Jun 18, 2008 33.4 KB View HTML View PDF View XLS  
4 neff, p sherrill Jun 13, 2008 24.6 KB View HTML View PDF View XLS  
8-K current report Jun 12, 2008 178.9 KB View HTML View PDF View XLS  
4 topper, james n Jun 12, 2008 24.6 KB View HTML View PDF View XLS  
4 sblendorio, glenn Jun 12, 2008 24.5 KB View HTML View PDF View XLS  
4 lockhart, david j Jun 12, 2008 24.8 KB View HTML View PDF View XLS  
4 hayden, donald j jr Jun 12, 2008 24.5 KB View HTML View PDF View XLS  
4 bloch, stephen m Jun 12, 2008 24.5 KB View HTML View PDF View XLS  
4 weinhoff, gregory m Jun 12, 2008 24.7 KB View HTML View PDF View XLS  
4 barkas, alexander e Jun 12, 2008 24.6 KB View HTML View PDF View XLS  
4 raab, michael Jun 11, 2008 24.4 KB View HTML View PDF View XLS  
SC 13G/A amended statement of beneficial ownership Jun 10, 2008 36.4 KB View HTML View PDF  
4 crowley, john f Jun 6, 2008 36.9 KB View HTML View PDF View XLS  
4 dentzer, james e Jun 4, 2008 24.7 KB View HTML View PDF View XLS  
4 crowley, john f Jun 4, 2008 38.5 KB View HTML View PDF View XLS  
SC 13G statement of beneficial ownership May 19, 2008 36.4 KB View HTML View PDF  
10-Q quarterly report May 14, 2008 257.0 KB View HTML View PDF View XLS  
Showing 561-580 of 797 Page: 1 ... 25 26 27 28 29 30 31 32 33 ... 40  Previous 20 | Next 20

Copyright © 2014 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy